Recent advances in diverticular disease

Current Gastroenterology Reports

Volumn 6, Issue 5, 2004, Pages 417-422

  Simpson, John ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; BARIUM; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; ENEMA; GALANIN; NEUROPEPTIDE K; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; STEROID; SUBSTANCE P;

COLON DIVERTICULOSIS; DIET THERAPY; DIETARY FIBER; DISEASE ASSOCIATION; DRUG MECHANISM; GASTROINTESTINAL DISEASE; HEART DISEASE; HIGH RISK PATIENT; HUMAN; INTESTINE INNERVATION; INTESTINE PERFORATION; INTESTINE PRESSURE; LARGE INTESTINE DISEASE; MANOMETRY; MORBIDITY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SYMPTOMATOLOGY;

EID: 8344252826     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-004-0060-z     Document Type: Review

References (53)

1. Parks TG: Natural history of diverticular disease of the colon. Clin Gastroenterol 1975, 4:53-69.
2. Cortesini C, Pantalone D: Usefulness of colonic motility study in identifying patients at risk for complicated diverticular disease. Dis Colon Rectum 1991, 34:339-342.
3. Papagrigoriadis S, Debrah S, Koreli A, et al.: Impact of diverticular disease on hospital costs and activity. Colorectal Dis 2004, 6:81-84.
4. Kang JY, Hoare J, Tinto A, et al.: Diverticular disease of the colon-on the rise: a study of hospital admissions in England between 1989/1990 and 1999/2000. Aliment Pharmacol Ther 2003, 17:1189-1195.
5. Hinchey EJ, Schaal PG, Richards GK: Treatment of perforated diverticular disease of the colon. Adv Surg 1978, 12:85-109.
6. Hart AR, Kennedy HJ, Stebbings WS, et al.: How frequently do large bowel diverticula perforate? An incidence and cross-sectional study. Eur J Gastroenterol Hepatol 2000, 12: 61-665.
7. Elliott TB, Yego S, Irvin TT: Five-year audit of the acute complications of diverticular disease. Br J Surg 1997, 84: 35-539.
8. Tudor RG, Farmakis N, Keighley MR: National audit of complicated diverticular disease: analysis of index cases. Br J Surg 1994, 81:730-732.
9. Simpson J, Scholefield JH, Spiller RC: Pathogenesis of colonic diverticula. Br J Surg 2002, 89:546-554.
10. Bjarnason I, Hayllar J, MacPherson AJ, et al.: Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993, 104:1832-1847.
11. Mpofu S, Mpofu CM, Hutchinson D, et al.: Steroids, non-steroidal anti-inflammatory drugs, and sigmoid diverticular abscess perforation in rheumatic conditions. Ann Rheum Dis 2004, 63: 88-590.
12. Davies NM: Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 1995, 38: 311-1321 1995.
13. Davies NM: Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability. Aliment Pharmacol Ther 1998, 12:303-320.
14. Morris CR, Harvey IM, Stebbings WS, et al.: Epidemiology of perforated colonic diverticular disease. Postgrad Med J 2002, 78:654-658.
15. Morris CR, Harvey IM, Stebbings WS, et al.: Anti-inflammatory drugs, analgesics and the risk of perforated colonic diverticular disease. Br J Surg 2003, 90:1267-1272.
16. Gianotti L, Alexander JW, Fukushima R, et al.: Steroid therapy can modulate gut barrier function, host defense, and survival in thermally injured mice. J Surg Res 1996, 62: 3-58.
17. Anstead GM: Steroids, retinoids, and wound healing. Adv Wound Care 1998, 11:277-285.
18. Canter JW, Shorb PE Jr: Acute perforation of colonic diverticula associated with prolonged adrenocorticosteroid therapy. Am J Surg 1971, 121:46-51.
19. Corder A: Steroids, non-steroidal anti-inflammatory drugs, and serious septic complications of diverticular disease. Br Med J 1987, 295:1238.
20. Painter NS, Truelove SC: The intraluminal pressure patterns in diverticulosis of the colon: part I and II. Gut 1964, 5:201-213.
21. Morris CR, Harvey IM, Stebbings WS, et al.: Do calcium channel blockers and antimuscarinics protect against perforated colonic diverticular disease? A case control study. Gut 2003, 52:1734-1737.
22. Sedrish SA, Venugopalan CS, Holmes EP, et al.: In vitro response of large colon arterial and venous rings to vasodilating drugs in horses. Am J Vet Res 1999, 60:204-210.
23. Gallavan Jr RH, Schwartz M, Tabata M: A comparison of the effects of nifedipine and nitrendipine on intestinal vascular smooth muscle and intestinal blood flow [abstract]. Gastroenterology 1983, 84:1161.
24. Bassotti G, Calcara C, Annese V, et al.: Nifedipine and verapamil inhibit the sigmoid colon myoelectric response to eating in healthy volunteers. Dis Colon Rectum 1998, 41:377-380.
25. Simpson J, Spiller RC: Colonic diverticular disease. Clin Evid 2001, 5:296-302.
26. Simpson J, Neal KR, Scholefield JH, et al.: Patterns of pain in diverticular disease and the influence of acute diverticulitis. Eur J Gastroenterol Hepatol 2003, 15: 005-1010.
27. Bolster LT, Papagrigoriadis S: Diverticular disease has an impact on quality of life: results of a preliminary study. Colorectal Dis 2003, 5:320-323.
28. Simpson J, Scholefield JH, Spiller RC: Origin of symptoms in diverticular disease. Br J Surg 2003, 90:899-908.
29. Painter NS, Truelove SC, Ardran GM, et al.: Segmentation and the localization of intraluminal pressure in the human colon, with special reference to the pathogenesis of colonic diverticula. Gastroenterology 1965, 49:169-177.
30. Arfwidsson S: Pathogenesis of multiple diverticula of the sigmoid colon in diverticular disease. Acta Chir Scand 1964, 63(Suppl 342):1-68.
31. Weinreich J, Andersen D: Intraluminal pressure in the sigmoid colon. II. Patients with sigmoid diverticula and related conditions. Scand J Gastroenterol 1976, 11:581-586.
32. Eastwood MA, Smith AN, Brydon WG, et al.: Colonic function in patients with diverticular disease. Lancet 1978, 1:1181-1182.
33. Eastwood MA, Watters DA, Smith AN: Diverticular disease: Is it a motility disorder? Clin Gastroenterol 1982, 11: 45-561.
34. Clemens CH, Samsom M, Roelofs J, et al.: Colorectal visceral perception in diverticular disease. Gut 2004, 33: 17-722.
35. Mertz H, Naliboff B, Munakata J, et al.: Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995, 109:40-52.
36. Zollinger RW: The prognosis in diverticulitis of the colon. Arch Surg 1968, 97: 418-422.
37. Neal KR, Hebden J, Spiller R: Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997, 314:779-782.
38. Isgar B, Harman M, Kaye MD, et al.: Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983, 24:190-192.
39. Delvaux M: Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut 2002, 51(Suppl 1):I67-I71.
40. Mayer EA, Gebhart GF: Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994, 107:271-293.
41. Bueno L, Fioramonti J, Delvaux M, et al.: Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations. Gastroenterology 1997, 112:1714-1743.
42. Simpson J, Haji-Suyoi A, Jenkins D, et al.: Quantification of neurological changes in resection specimens with complicated and uncomplicated diverticular disease [abstract]. Gastroenterology 2002, 122:A314.
43. McLean PC, Picard C, Garcia-Villar R, et al.: Effects of nematode infection on sensitivity to intestinal distension: role of tachykinin NK2 receptors. Eur J Pharmacol 1997, 337: 79-282.
44. Kirkup AJ, Brunsden AM, Grundy D: Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am J Physiol Gastrointest Liver Physiol 2001, 280:G787-G794.
45. De Giorgio R, Stanghellini V, Barbara G, et al.: Primary enteric neuropathies underlying gastrointestinal motor dysfunction. Scand J Gastroenterol 2000, 35:114-122.
46. Tornblom H, Lindberg G, Veress B: Histopathological findings in the jejunum of patients with severe irritable bowel syndrome [abstract]. Gastroenterology 2000, 118:A140.
47. Dvorak AM, Osage JE, Monahan RA, et al.: Crohn's disease: transmission electron microscopic studies. III. Target tissues: proliferation of and injury to smooth muscle and the autonomic nervous system. Hum Pathol 1980, 11:620-634.
48. Jacobson K, McHugh K, Collins SM: Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 1995, 109:718-722.
49. Barbara G, Vallance BA, Collins SM: Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997, 113:1224-1232.
50. Maio Y, Wang L, Chen Y, et al.: Hyperalgesic colonic sensory afferent pathways following T. Spiralis enteritis, involvement of NK1 receptors [abstract]. Gastroenterology 2000, 118:A701.
51. Simpson J, Sundler F, Jenkins D, et al.: Increased expression of substance P, neurpeptide K and galanin in mucosal nerves in patients with painful diverticular disease [abstract]. Gastroenterology 2004, 126:A218.
52. Golder M, Burleigh DE, Belai A, et al.: Smooth muscle cholinergic denervation hypersensitivity in diverticular disease. Lancet 2003, 361:1945-1951.
53. Farthmann EH, Ruckauer KD, Haring RU: Evidence-based surgery: diverticulitis - a surgical disease? Langenbecks Arch Surg 2000, 385:143-151.